Skip to main content
Livermore
Livermore
ZHEN

Alps Advisors Inc

SEC CIK
0001376113
Latest filing
Jul 29, 2026

XENE holding history

Xenon Pharmaceuticals Inc. in every 13F filed by Alps Advisors Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

XENE overviewAll 13F holders of XENEFull Q2 2026 holdings

Shares (Q2 2026)
97,610
Value
$5.89M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of XENE by Alps Advisors Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202697,610$5.89M<0.1%+29,887+44.1%AddedHolders
Q1 202667,723$3.94M<0.1%+4,421+7.0%AddedHolders
Q4 202563,302$2.84M<0.1%+26,002+69.7%AddedHolders
Q3 202537,300$1.50M<0.1%−4,080−9.9%ReducedHolders
Q2 202541,380$1.30M<0.1%−13,952−25.2%ReducedHolders
Q1 202555,332$1.86M<0.1%−6,316−10.2%ReducedHolders
Q4 202461,648$2.42M<0.1%+4,659+8.2%AddedHolders
Q3 202456,989$2.24M<0.1%−1,864−3.2%ReducedHolders
Q2 202458,853$2.29M<0.1%+5,653+10.6%AddedHolders
Q1 202453,200$2.29M<0.1%+2,420+4.8%AddedHolders
Q4 202350,780$2.34M<0.1%+3,431+7.2%AddedHolders
Q3 202347,349$1.62M<0.1%+626+1.3%AddedHolders
Q2 202346,723$1.80M<0.1%+5,195+12.5%AddedHolders
Q1 202341,528$1.49M<0.1%−843−2.0%ReducedHolders
Q4 202242,371$1.67M<0.1%+8,412+24.8%AddedHolders
Q3 202233,959$1.23M<0.1%+2,461+7.8%AddedHolders
Q2 202231,498$958.0K<0.1%+31,498NewHolders
Q1 20220$00.0%−59,702−100.0%Sold outHolders
Q4 202159,702$1.86M<0.1%+9,287+18.4%AddedHolders
Q3 202150,415$770.0K<0.1%−3,544−6.6%ReducedHolders
Q2 202153,959$1.00M<0.1%−9,372−14.8%ReducedHolders
Q1 202163,331$1.13M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.